| Page 1891 | Kisaco Research
 

Jisoo Pae, MD, Psychiatrist, MBA

Chief Executive Officer
Genome & Company

Jisoo Pae, MD, Psychiatrist, MBA

Chief Executive Officer
Genome & Company

Jisoo Pae, MD, Psychiatrist, MBA

Chief Executive Officer
Genome & Company
 
29-30 Jan 2019
Washington DC, USA
The Phage Futures Congress will bring together peers from biotech companies and academia, along with experts from regulatory bodies, pharmaceutical companies and government institutions, to discuss how to actively progress clinical science and viable phage application routes to market. You will hear about:Regulatory guidance to achieve clinical data from Cara Fiore, FDAStrategies to access the market via the veterinary, personalized medicine and traditional pharmaceutical routesInsights into investment drivers for phage therapy from NIH and Boehringer IngelheimFacts on how to manufacture GMP phageApplications to overcome multi-drug resistance with combined approaches such as phage therapy and antibiotics "This congress has the potential to act as a catalyst to further cooperative and collaborative efforts to develop alternate Phage based approaches to the antibiotic crisis. In addition, the location in the Washington DC area will facilitate an opportunity for Government Agencies, responsible for public health, such as the NIH, FDA, USDA and DOD to participate and interact with educational research groups and biotechnology companies developing phage therapies and initiating clinical testing." - Carl Merril, Adaptive Phage Therapeutics
 

Dr Annika Schrader

Global Marketing Manager Active Ingredients
Evonik Nutrition & Personal Care

After finalizing her study of neurobiology at the University of Oldenburg, she conducted a PhD at the Beiersdorf AG in Hamburg, where she afterwards was responsible for the R&D lab “Dry aged skin”.

In 2013, she joined Evonik in the area of Innovation Management for cosmetic active ingredients, where she is now responsible for global marketing.

Dr Annika Schrader

Global Marketing Manager Active Ingredients
Evonik Nutrition & Personal Care

Dr Annika Schrader

Global Marketing Manager Active Ingredients
Evonik Nutrition & Personal Care

After finalizing her study of neurobiology at the University of Oldenburg, she conducted a PhD at the Beiersdorf AG in Hamburg, where she afterwards was responsible for the R&D lab “Dry aged skin”.

In 2013, she joined Evonik in the area of Innovation Management for cosmetic active ingredients, where she is now responsible for global marketing.

 

Greg Gonzalez

Founder
Youth To The People

Joe Cloyes and Greg Gonzalez are the founders of the superfood-powered skincare company, Youth To The People, a brand focused on uniting modern wellness with proven skincare science. Joe and Greg make up the third generation of a family deeply involved in the industry, originating with their grandmother’s company, Eva’s Esthetics, one of the first companies to bring naturals to the professional American skincare industry. Youth To The People is based out of Downtown Los Angeles.

Greg Gonzalez

Founder
Youth To The People

Greg Gonzalez

Founder
Youth To The People

Joe Cloyes and Greg Gonzalez are the founders of the superfood-powered skincare company, Youth To The People, a brand focused on uniting modern wellness with proven skincare science. Joe and Greg make up the third generation of a family deeply involved in the industry, originating with their grandmother’s company, Eva’s Esthetics, one of the first companies to bring naturals to the professional American skincare industry. Youth To The People is based out of Downtown Los Angeles.

 

Joe Cloyes

Founder & CEO
Youth To The People

Joe Cloyes and Greg Gonzalez are the founders of the superfood-powered skincare company, Youth To The People, a brand focused on uniting modern wellness with proven skincare science. Joe and Greg make up the third generation of a family deeply involved in the industry, originating with their grandmother’s company, Eva’s Esthetics, one of the first companies to bring naturals to the professional American skincare industry. Youth To The People is based out of Downtown Los Angeles.

Joe Cloyes

Founder & CEO
Youth To The People

Joe Cloyes

Founder & CEO
Youth To The People

Joe Cloyes and Greg Gonzalez are the founders of the superfood-powered skincare company, Youth To The People, a brand focused on uniting modern wellness with proven skincare science. Joe and Greg make up the third generation of a family deeply involved in the industry, originating with their grandmother’s company, Eva’s Esthetics, one of the first companies to bring naturals to the professional American skincare industry. Youth To The People is based out of Downtown Los Angeles.

 

Sarah Jindal

Senior Global Analyst, Innovation and Insights Beauty & Personal Care
Mintel

Sarah is Mintel’s Senior Innovation and Insights Analyst and has over 16 years of experience developing ingredient technologies for beauty and personal care companies. Having worked for a variety of companies over her career, Sarah has gained an in-depth understanding of the industry and draws upon not only her work experience but also degrees in Biology, Biochemistry, and Evolutionary Biology

Sarah Jindal

Senior Global Analyst, Innovation and Insights Beauty & Personal Care
Mintel

Sarah Jindal

Senior Global Analyst, Innovation and Insights Beauty & Personal Care
Mintel

Sarah is Mintel’s Senior Innovation and Insights Analyst and has over 16 years of experience developing ingredient technologies for beauty and personal care companies. Having worked for a variety of companies over her career, Sarah has gained an in-depth understanding of the industry and draws upon not only her work experience but also degrees in Biology, Biochemistry, and Evolutionary Biology

 

Jennifer Myers

Senior Director of Engineering, AI Software
Intel

Jennifer Myers is a Senior Director of Engineering at Intel. She leads teams optimizing Deep Learning frameworks for Intel CPUs, as well as the teams developing the nGraph Deep Learning compiler. nGraph is an Open Source project aiming to optimize both training and inference across a wide variety of frameworks, topologies and backends (CPU, GPU, FPGA, DL accelerators). Jennifer joined Intel as part of the Nervana Systems acquisition in 2016.

Jennifer Myers

Senior Director of Engineering, AI Software
Intel

Jennifer Myers

Senior Director of Engineering, AI Software
Intel

Jennifer Myers is a Senior Director of Engineering at Intel. She leads teams optimizing Deep Learning frameworks for Intel CPUs, as well as the teams developing the nGraph Deep Learning compiler. nGraph is an Open Source project aiming to optimize both training and inference across a wide variety of frameworks, topologies and backends (CPU, GPU, FPGA, DL accelerators). Jennifer joined Intel as part of the Nervana Systems acquisition in 2016.  Prior to this, she had a 20+ year career in technical leadership positions across a variety of startups and Sun Microsystems, innovating in search and ads systems and relevance, email, secure network storage, video compression and streaming and network security. She was introduced to Deep Learning in a graduate course on Parallel and Distributed Processing her freshman year at Carnegie Mellon University, and holds a Ph.D. from Northwestern University in Neuroscience, where her thesis was in neural network modeling of human arm movement.

 

Casimir Wierzynski

Senior Director
Intel

Casimir Wierzynski is Senior Director, Office of the CTO, in the Artificial Intelligence Product Group at Intel Corporation.  He leads research efforts to identify, synthesize, and incubate emerging technologies that will enable the next generation of AI systems.

Before joining Intel in 2017, Cas led research teams in neuromorphic computing, learning and AI planning, and autonomous robotics at Qualcomm. Prior to Qualcomm, Cas was a Vice President at Goldman Sachs, where he traded fixed income andcredit derivatives. 

Casimir Wierzynski

Senior Director
Intel

Casimir Wierzynski

Senior Director
Intel

Casimir Wierzynski is Senior Director, Office of the CTO, in the Artificial Intelligence Product Group at Intel Corporation.  He leads research efforts to identify, synthesize, and incubate emerging technologies that will enable the next generation of AI systems.

Before joining Intel in 2017, Cas led research teams in neuromorphic computing, learning and AI planning, and autonomous robotics at Qualcomm. Prior to Qualcomm, Cas was a Vice President at Goldman Sachs, where he traded fixed income andcredit derivatives. 

Cas received his BS and MS in electrical engineering at MIT, completing his master’s thesis at AT&T Bell Labs, and a BA in mathematics at Cambridge University as a British Marshall Scholar. Driven by his passion for AI and the brain, Cas left finance to receive his PhD at Caltech in Computation andNeural Systems, where he used large-scale neural recordings to study the relationship between memory consolidation and sleep. At Caltech he received a NDSEG Fellowship, a Beckman Fellowship, a Helen Hay Whitney Fellowship, andthe Ferguson Prize for the best doctoral thesis in biology.